Comparison of the risk of fatal coronary heart disease in treated xanthomatous and non-xanthomatous heterozygous familial hypercholesterolaemia: a prospective registry study
- 1 September 2003
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 170 (1) , 73-78
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemiaAtherosclerosis, 2003
- Risk of Fatal Stroke in Patients With Treated Familial HypercholesterolemiaStroke, 2003
- Inhibition of Intestinal Cholesterol Absorption by Ezetimibe in HumansCirculation, 2002
- Randomised controlled trial of use by hypercholesterolaemic patients of a vegetable oil sterol-enriched fat spreadAtherosclerosis, 2001
- A novel single base deletion in the LDLR gene (211delG): Effect on serum lipid profiles and the influence of other genetic polymorphisms in the ACE, APOE and APOB genesAtherosclerosis, 1996
- Diagnosis of heterozygous familial hypercholesterolemia. DNA analysis complements clinical examination and analysis of serum lipid levels.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992
- Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group.BMJ, 1991
- Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimensJAMA, 1990
- Coronary Artery Disease in 116 Kindred with Familial Type II HyperlipoproteinemiaCirculation, 1974
- RISKS OF ISCHÆMIC HEART-DISEASE IN FAMILIAL HYPERLIPOPROTEINÆMIC STATESThe Lancet, 1969